Bioinformatics analysis of differential genes and potential therapeutic drugs in primary Sjgren's syndrome
Xu Huaa, Chen Jiab
2020, 35(6):
533-540.
doi:10.3969/j.issn.1004-583X.2020.06.011
Asbtract
(
595 )
PDF (1410KB)
(
238
)
HTML
Related Articles |
Metrics
Objective To screen genes associated with primary Sjgren's syndrome (PSS) and potential small molecule therapeutic drugs by gene expression profiles. Methods The expression profiles of three PSS related genes were obtained and analyzed in GEO databaseto obtain differentially expressed genes.Furthermore,GO and KEGG enrichmentanalysiswere carried out on the differential genes, andthehub genes of PSS were screened and verified by PPI. Finally, CMAP database was used to predict the potential therapeutic drugs of PSS, and the role of potential drugs in PSS treatment was discussed in combination with drug targets and drug pathways. Results A total of 90 PSS related differential genes were identified, including 79 upregulated genes and 11 downregulated genes, which were mainly involved in NODlike receptor signaling pathway, Influenza A and cytokinecytokine receptor interaction pathway. In addition, through screening and verification, 19hub genes (STAT1, MX1, ISG15, IFIH1, GBP1, IFIT1, XAF1, RSAD2, IFIT2, SAMD9L, TRIM22, IFIT3, IFI44L, HERC5, IFIT5, IFI44, IFI6, RTP4 and ISG20) were identified, most of which were interferoninduced genes. Interferon may play an important role in the pathogenesis of PSS. Finally, 15 candidate drugs such as fluticasone and cloxacillin were selected through CMAP database, and their action pathways and targets were analyzed.Conclusion In this study,through the screening of PSS hub genes and candidate drugs,we can further getanin sight into the pathogenesis of PSS and the studyprovides clues for thefurther study of PSS.